The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
32
No.
14
April 14, 2006
- Remarks on HPV Vaccines, SPORE Funds Create Controversy for NCI’s John Niederhuber.
- NCI Official Says He Hopes to “Put More Money” Into SPOREs.
- AACR Meeting: Celebrex Studies Show Benign Polyp Reduction, Point To Challenges In Biomarker Validation.
- Advocacy: NCCS, ASCO Petition FDA To Set Standards For Expanded Access Programs.
TCL
Vol.
32
No.
15
April 21, 2006
- A Message From NCI: “We Deeply Regret The Need To Eliminate This Program.” AP4 Applicants And Corporate Partners Spent Years, Money, Before NCI Pulled The Plug On Novel Public-Private Partnerships. Von Eschenbach Called AP4 “A New Paradigm” For Drug Development. NCI Executive Committee “Prioritized” Programs.
- Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.
CCL
Vol.
29
No.
4
April 28, 2006
- NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction
- Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation
- Benefit Of Chemotherapy Depends ER Status
- WHI Update: No Increased Risk Of Cancer With Estrogen-Alone
- Panitumumab Improves PFS In Metastatic Colon Cancer
- NCI-Approved Trials Listed
TCL
Vol.
32
No.
18
May 12, 2006
- NCI Tells CCOPs To Slow Patient Accrual To Clinical Trials, Prepare For Budget Cuts.
- Wichita CCOP Stopped Accrual For Two Months, PI Says.
- MSKCC Gets $100 Million Commitment From Mortimer Zuckerman For New Research Building.
- National Breast Cancer Coalition Seeks Nominations For “Golden Boob Award.”
- House Committee Adds $4.1 Billion To HHS Budget, Funds Not Expected To Help NIH.
TCL
Vol.
32
No.
19
May 19, 2006
TCL
Vol.
32
No.
20
May 26, 2006
- Legislation Would Create Medicare Service For Comprehensive Cancer Care planning.
- Bill Would Improve Quality Of Care, Close Gaps in Services, Supporters Say. Sen. Arlen Specter to NIH Advocates: “Be More Politically Active;” Asks NCI For “A Winning Strategy.”
- Group Opposes Bill To Allow Drug Sales After Phase I.
- FDA Encourages Randomized Trials For Medical Devices.
- NCI Begins TAILORx Study.
